ChemGenex Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

ChemGenex Pharmaceuticals Ownership

Who owns ChemGenex Pharmaceuticals?

ChemGenex Pharmaceuticals is owned by Cephalon. It was acquired on March 28, 2011.

ChemGenex Pharmaceuticals Business Overview

Where is ChemGenex Pharmaceuticals headquartered?

ChemGenex Pharmaceuticals is headquartered in Menlo Park, California.

How many employees does ChemGenex Pharmaceuticals have?

ChemGenex Pharmaceuticals has 19 employees.

What sector is ChemGenex Pharmaceuticals in?

ChemGenex Pharmaceuticals is a life science company.

When was ChemGenex Pharmaceuticals founded?

ChemGenex Pharmaceuticals was founded in 1958.

Life Science M&A Summary in 2011

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2011. The largest life science acquisition in 2011 was Genzyme - which was acquired by Sanofi SA for $20.1B.

Join Mergr to view all 171 acquisitions of life science companies in 2011, including 23 acquisitions by private equity firms, and 148 by strategics.

ChemGenex Pharmaceuticals, Inc.

Level 4, 199 Moorabool Street,
Menlo Park, California VIC 3220
United States,
+61 3 5223 9900
www.chemgenex.com

ChemGenex Pharmaceuticals is a pharmaceutical development company dedicated to improving the lives of patients by developing personalized therapeutics in the areas of oncology, diabetes and obesity. ChemGenex’s lead compound, Ceflatonin®, is currently in Phase 2/3 clinical trials for chronic myeloid leukemia and Quinamed® is in Phase 2 clinical trials for several solid cancers. ChemGenex's pipeline also includes several pre-clinical stage anti-diabetes lead mole.


 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.